Profiles

Keywords
Last Name
Institution

Annabelle Volgman

Concepts (317)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
19
2021
193
7.610
Why?
Cardiovascular Diseases
16
2021
391
4.420
Why?
Stroke
18
2021
345
4.040
Why?
Healthcare Disparities
6
2020
79
2.060
Why?
Anticoagulants
5
2016
147
1.980
Why?
Heart Failure
6
2021
231
1.920
Why?
Sex Factors
17
2021
535
1.870
Why?
Female
66
2021
18107
1.860
Why?
Humans
81
2021
30741
1.690
Why?
Coronary Artery Disease
6
2020
154
1.650
Why?
Risk Factors
27
2021
2611
1.570
Why?
Exercise
6
2020
431
1.510
Why?
Hospital Mortality
6
2021
187
1.500
Why?
Myocardial Infarction
8
2021
191
1.490
Why?
Hospitalization
8
2021
344
1.480
Why?
Life Style
8
2020
208
1.470
Why?
Women's Health
4
2020
220
1.460
Why?
Cardiology
4
2021
99
1.400
Why?
Risk Assessment
13
2021
804
1.360
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
75
1.300
Why?
Sex Characteristics
5
2021
126
1.260
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
30
1.180
Why?
Primary Prevention
3
2020
43
1.180
Why?
Adrenergic beta-Antagonists
2
2020
45
1.170
Why?
Health Status Disparities
4
2019
68
1.160
Why?
Aged
36
2021
10156
1.160
Why?
Arrhythmias, Cardiac
6
2019
169
1.140
Why?
Defibrillators, Implantable
3
2021
38
1.110
Why?
Physicians, Women
2
2021
14
1.100
Why?
Male
40
2021
17552
1.040
Why?
Myocardial Ischemia
2
2021
62
1.030
Why?
Catheter Ablation
2
2020
78
1.020
Why?
United States
23
2021
2467
1.000
Why?
American Heart Association
3
2021
35
1.000
Why?
Echocardiography, Doppler, Color
2
2019
15
0.990
Why?
Middle Aged
30
2021
11256
0.930
Why?
Coronavirus
1
2021
4
0.910
Why?
Pregnancy Complications, Cardiovascular
5
2021
16
0.910
Why?
Electrocardiography
7
2015
231
0.890
Why?
Breast Neoplasms
3
2021
440
0.880
Why?
Length of Stay
4
2020
371
0.850
Why?
Chest Pain
1
2020
23
0.850
Why?
Social Media
1
2021
32
0.840
Why?
Endothelium
1
2020
15
0.840
Why?
Patient Care Management
2
2021
16
0.810
Why?
Brain Ischemia
1
2021
117
0.810
Why?
Anti-Arrhythmia Agents
5
2020
105
0.800
Why?
Vascular Diseases
1
2020
58
0.800
Why?
Quality of Life
4
2020
636
0.790
Why?
Takotsubo Cardiomyopathy
1
2019
20
0.790
Why?
Myxoma
1
2019
7
0.790
Why?
Cardiomyopathies
1
2019
37
0.780
Why?
Heart Neoplasms
1
2019
21
0.780
Why?
Heart Failure, Diastolic
1
2018
2
0.770
Why?
Women's Health Services
1
2018
12
0.760
Why?
Comorbidity
5
2021
562
0.750
Why?
Culturally Competent Care
1
2018
10
0.740
Why?
Heart Diseases
1
2020
102
0.740
Why?
Ambulatory Care Facilities
1
2018
41
0.730
Why?
Age Factors
8
2021
941
0.730
Why?
Delivery of Health Care, Integrated
1
2018
30
0.730
Why?
Prevalence
6
2020
546
0.730
Why?
Emigrants and Immigrants
1
2018
25
0.720
Why?
Atherosclerosis
1
2018
48
0.720
Why?
Warfarin
3
2016
61
0.710
Why?
Coronavirus Infections
1
2020
97
0.710
Why?
Pneumonia, Viral
1
2020
104
0.710
Why?
Heart Ventricles
1
2019
220
0.710
Why?
Antineoplastic Agents
1
2020
321
0.660
Why?
Lipoprotein(a)
1
2016
10
0.630
Why?
Dyslipidemias
1
2016
24
0.620
Why?
Cognition
3
2020
1141
0.620
Why?
Electrodes
1
2015
17
0.600
Why?
Prognosis
7
2021
1045
0.600
Why?
Cost of Illness
1
2015
65
0.580
Why?
Treatment Outcome
11
2020
3850
0.570
Why?
Social Support
1
2016
217
0.560
Why?
Electric Countershock
6
2020
30
0.530
Why?
Patient Readmission
3
2019
124
0.530
Why?
Aspirin
2
2020
89
0.530
Why?
Health Knowledge, Attitudes, Practice
1
2016
228
0.520
Why?
Magnetic Resonance Imaging
1
2019
1244
0.510
Why?
Aged, 80 and over
9
2021
5172
0.500
Why?
Patient Acceptance of Health Care
1
2012
83
0.460
Why?
Coronary Angiography
3
2020
106
0.450
Why?
Adult
13
2020
9760
0.440
Why?
Cardiovascular System
2
2021
10
0.430
Why?
Acute Kidney Injury
2
2021
59
0.420
Why?
Pregnancy
6
2021
452
0.410
Why?
Cardiac Resynchronization Therapy Devices
2
2019
10
0.410
Why?
Cardiovascular Agents
2
2021
34
0.410
Why?
Transcatheter Aortic Valve Replacement
2
2020
27
0.410
Why?
Aortic Valve Stenosis
2
2020
29
0.410
Why?
Hospital Costs
2
2020
74
0.390
Why?
Feasibility Studies
2
2020
283
0.390
Why?
Diabetes Mellitus
2
2020
140
0.380
Why?
Practice Guidelines as Topic
3
2021
389
0.350
Why?
Secondary Prevention
2
2018
64
0.350
Why?
Ventricular Fibrillation
2
2021
35
0.350
Why?
Heart Atria
2
2019
95
0.340
Why?
Retrospective Studies
8
2021
3456
0.340
Why?
Hypertension
5
2020
272
0.340
Why?
Administration, Oral
3
2016
165
0.300
Why?
Health Status
2
2018
252
0.300
Why?
Sex Distribution
3
2019
91
0.300
Why?
Randomized Controlled Trials as Topic
5
2020
361
0.300
Why?
Hemorrhage
5
2020
88
0.290
Why?
Antihypertensive Agents
2
2020
91
0.280
Why?
Risk Adjustment
2
2021
14
0.280
Why?
African Americans
3
2016
780
0.270
Why?
Hospital Charges
2
2020
23
0.270
Why?
Incidence
4
2020
827
0.270
Why?
Logistic Models
3
2021
479
0.270
Why?
Obesity
4
2020
322
0.260
Why?
Aortic Valve
2
2020
34
0.260
Why?
Illinois
2
2021
268
0.260
Why?
Cardiotoxicity
2
2020
9
0.260
Why?
Age Distribution
2
2020
116
0.260
Why?
Morbidity
2
2019
71
0.250
Why?
Young Adult
3
2020
2249
0.250
Why?
Health Promotion
2
2016
183
0.240
Why?
Cardiac Electrophysiology
1
2021
3
0.240
Why?
Coronary Circulation
2
2020
49
0.230
Why?
Troponin
1
2021
11
0.230
Why?
Shock, Cardiogenic
1
2021
11
0.230
Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.230
Why?
Societies, Medical
2
2020
203
0.230
Why?
Sexism
1
2021
8
0.230
Why?
Water-Electrolyte Imbalance
1
2021
3
0.230
Why?
Hormones
1
2021
19
0.230
Why?
Death, Sudden, Cardiac
1
2021
28
0.230
Why?
Women's Rights
1
2021
3
0.220
Why?
Adolescent
2
2020
2627
0.220
Why?
National Institutes of Health (U.S.)
1
2021
33
0.220
Why?
Angioplasty
1
2020
16
0.220
Why?
Pacemaker, Artificial
2
2019
48
0.220
Why?
Signal Processing, Computer-Assisted
2
1998
44
0.220
Why?
Health Expenditures
1
2020
20
0.220
Why?
Hyperlipidemias
1
2020
27
0.220
Why?
Career Choice
1
2021
32
0.220
Why?
Cross-Sectional Studies
4
2017
957
0.220
Why?
Physician-Patient Relations
1
2021
47
0.220
Why?
Peripheral Arterial Disease
1
2020
20
0.220
Why?
Heart Valve Diseases
1
2020
33
0.220
Why?
Periodicals as Topic
1
2021
42
0.220
Why?
Postoperative Hemorrhage
1
2020
30
0.210
Why?
Disease Outbreaks
1
2021
89
0.210
Why?
Myocardial Revascularization
1
2020
25
0.210
Why?
Postnatal Care
1
2020
9
0.210
Why?
Delivery, Obstetric
1
2020
15
0.210
Why?
Radiation-Protective Agents
1
2020
4
0.210
Why?
Colchicine
1
2020
9
0.210
Why?
Protective Factors
1
2020
18
0.210
Why?
Leadership
1
2021
100
0.210
Why?
Social Class
1
2020
72
0.210
Why?
After-Hours Care
1
2019
1
0.200
Why?
Income
1
2020
71
0.200
Why?
Endovascular Procedures
1
2020
78
0.200
Why?
Heart Valve Prosthesis Implantation
1
2020
46
0.200
Why?
Odds Ratio
2
2020
328
0.200
Why?
Prostatic Neoplasms
1
2021
141
0.200
Why?
Global Health
1
2019
57
0.200
Why?
Radiation Injuries
1
2020
44
0.200
Why?
Thrombolytic Therapy
1
2020
84
0.200
Why?
Up-Regulation
2
2021
218
0.200
Why?
Cardiac Resynchronization Therapy
1
2019
23
0.200
Why?
Multimodal Imaging
1
2019
30
0.200
Why?
Health Behavior
1
2020
175
0.190
Why?
Clinical Trials as Topic
1
2021
386
0.190
Why?
Treatment Refusal
1
2018
14
0.190
Why?
Heart
1
2019
110
0.190
Why?
Asia, Western
1
2018
2
0.190
Why?
Indian Ocean Islands
1
2018
2
0.190
Why?
Procainamide
1
1998
24
0.190
Why?
Intensive Care Units
1
2021
300
0.180
Why?
Heart Transplantation
1
1998
52
0.180
Why?
Pandemics
1
2020
157
0.180
Why?
Atrial Flutter
1
1998
24
0.180
Why?
Graft Rejection
1
1998
85
0.180
Why?
Walking
1
2020
241
0.180
Why?
Sulfonamides
1
1998
66
0.180
Why?
Reproducibility of Results
3
2017
875
0.180
Why?
Memory Disorders
1
2019
180
0.170
Why?
Inpatients
1
2019
147
0.170
Why?
Diagnosis, Differential
1
2019
469
0.170
Why?
Lupus Erythematosus, Systemic
1
2020
190
0.170
Why?
Coronary Disease
2
2020
103
0.170
Why?
Diet Surveys
1
2017
24
0.170
Why?
Pyridones
1
2016
18
0.170
Why?
Patient Discharge
1
2018
160
0.170
Why?
Nutrition Assessment
1
2017
53
0.170
Why?
Thiazoles
1
2016
39
0.170
Why?
Evidence-Based Practice
1
2017
82
0.170
Why?
Pyridines
1
2016
48
0.160
Why?
Neoplasms
1
2020
275
0.160
Why?
Evidence-Based Medicine
1
2018
239
0.160
Why?
Georgia
1
2016
16
0.160
Why?
Patient Selection
2
2020
259
0.160
Why?
Diet, Mediterranean
1
2017
53
0.160
Why?
Cholesterol, LDL
1
2016
44
0.160
Why?
Sensitivity and Specificity
2
2015
594
0.160
Why?
Platelet Aggregation Inhibitors
1
2016
64
0.160
Why?
Pyrazoles
1
2016
55
0.160
Why?
Health Surveys
1
2016
101
0.150
Why?
Self Efficacy
1
2016
62
0.150
Why?
Miniaturization
1
2015
3
0.150
Why?
Preventive Health Services
1
2015
15
0.150
Why?
Equipment Design
2
2015
204
0.150
Why?
Asian Americans
1
2015
53
0.150
Why?
Chicago
2
2016
945
0.150
Why?
Equipment Failure Analysis
1
2015
117
0.140
Why?
Heart Rate
2
2009
165
0.140
Why?
Smoking
2
2018
197
0.130
Why?
Needs Assessment
1
2013
50
0.130
Why?
Cardiac Pacing, Artificial
2
1992
81
0.130
Why?
Drug Monitoring
1
2012
28
0.120
Why?
Activities of Daily Living
1
2016
472
0.120
Why?
Heart Conduction System
1
1992
36
0.120
Why?
Tachycardia
1
1992
50
0.120
Why?
Data Collection
1
2012
118
0.120
Why?
Echocardiography
3
2019
201
0.100
Why?
Percutaneous Coronary Intervention
2
2020
24
0.100
Why?
Coronary Vessels
1
1990
51
0.100
Why?
Motor Activity
1
2013
395
0.100
Why?
Coronary Artery Bypass
2
2020
76
0.100
Why?
Survival Rate
2
2019
478
0.090
Why?
Databases, Factual
2
2019
372
0.080
Why?
Azetidines
1
2006
4
0.080
Why?
Benzylamines
1
2006
15
0.080
Why?
Body Mass Index
2
2020
438
0.080
Why?
Severity of Illness Index
2
2021
1233
0.080
Why?
Time Factors
3
2021
1911
0.070
Why?
Endpoint Determination
1
2004
31
0.070
Why?
Cohort Studies
2
2019
1959
0.060
Why?
Postoperative Complications
2
2020
1084
0.060
Why?
Follow-Up Studies
2
2019
2046
0.060
Why?
Double-Blind Method
2
2006
550
0.060
Why?
Prospective Studies
2
1998
1891
0.060
Why?
Peripartum Period
1
2021
3
0.060
Why?
Pregnancy, High-Risk
1
2021
3
0.060
Why?
Chlorides
1
2021
27
0.060
Why?
Diuretics
1
2021
16
0.060
Why?
Recurrence
2
2006
390
0.060
Why?
Health Services Research
1
2021
45
0.060
Why?
Sodium
1
2021
77
0.050
Why?
Amputation
1
2020
20
0.050
Why?
Education, Medical
1
2021
45
0.050
Why?
Vascular Endothelial Growth Factor A
1
2020
75
0.050
Why?
Patient Preference
1
2021
34
0.050
Why?
Abortion, Spontaneous
1
2020
9
0.050
Why?
Fetal Growth Retardation
1
2020
4
0.050
Why?
Polycystic Ovary Syndrome
1
2020
5
0.050
Why?
Hypercholesterolemia
1
2020
38
0.050
Why?
Menopause, Premature
1
2020
7
0.050
Why?
Ischemic Attack, Transient
1
2020
27
0.050
Why?
Sleep Apnea, Central
1
2000
25
0.050
Why?
Lactation
1
2021
76
0.050
Why?
Health Care Costs
1
2020
82
0.050
Why?
Case-Control Studies
2
2000
694
0.050
Why?
Radiotherapy
1
2020
68
0.050
Why?
Attitude to Health
1
2020
116
0.050
Why?
Curriculum
1
2021
153
0.050
Why?
Autoimmune Diseases
1
2020
64
0.050
Why?
Costs and Cost Analysis
1
2019
39
0.050
Why?
Cause of Death
1
2019
74
0.050
Why?
Thrombectomy
1
2019
50
0.050
Why?
Multivariate Analysis
1
2020
391
0.050
Why?
Disease Management
1
2020
149
0.050
Why?
Psychology
1
2018
24
0.050
Why?
Health Services Needs and Demand
1
2018
69
0.050
Why?
Blood Pressure
1
2020
250
0.050
Why?
Heredity
1
2018
8
0.050
Why?
Diet, Western
1
2017
6
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
222
0.040
Why?
Quality Improvement
1
2018
169
0.040
Why?
Breast Feeding
1
2018
166
0.040
Why?
Waist Circumference
1
2015
34
0.040
Why?
Body Composition
1
2016
77
0.040
Why?
Risk
1
2016
232
0.040
Why?
Decision Making
1
2018
228
0.040
Why?
Drug Therapy, Combination
1
2016
266
0.040
Why?
Body Weight
1
2016
165
0.040
Why?
Genetic Predisposition to Disease
1
2018
473
0.040
Why?
Patient Compliance
1
2016
201
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
4
0.030
Why?
Dextroamphetamine
1
1993
6
0.030
Why?
Social Networking
1
2013
10
0.030
Why?
Syncope
1
1993
10
0.030
Why?
Hypotension, Orthostatic
1
1993
17
0.030
Why?
Efficiency
1
2013
21
0.030
Why?
Albuterol
1
1993
17
0.030
Why?
Bradycardia
1
1993
33
0.030
Why?
Cost-Benefit Analysis
1
2013
146
0.030
Why?
Interviews as Topic
1
2013
148
0.030
Why?
Program Evaluation
1
2013
152
0.030
Why?
Tachycardia, Ventricular
1
1992
39
0.030
Why?
Cardiac Catheterization
1
1992
115
0.030
Why?
Asthma
1
1993
179
0.030
Why?
Animals
1
2020
5221
0.030
Why?
Estrogen Replacement Therapy
1
2006
22
0.020
Why?
Thromboembolism
1
2006
38
0.020
Why?
Chi-Square Distribution
1
2006
181
0.020
Why?
Proportional Hazards Models
1
2006
385
0.020
Why?
Combined Modality Therapy
1
2004
473
0.020
Why?
Electrocardiography, Ambulatory
1
2000
23
0.010
Why?
Bronchoscopy
1
2000
38
0.010
Why?
Anesthesia
1
2000
27
0.010
Why?
Respiration
1
2000
36
0.010
Why?
Tracheostomy
1
2000
27
0.010
Why?
Child
1
2000
1547
0.010
Why?
False Positive Reactions
1
1993
40
0.010
Why?
Administration, Inhalation
1
1993
36
0.010
Why?
Posture
1
1993
88
0.010
Why?
Action Potentials
1
1993
141
0.010
Why?
ROC Curve
1
1992
155
0.010
Why?
Analysis of Variance
1
1992
369
0.010
Why?
Registries
1
1991
203
0.010
Why?
Volgman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description